TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program July 30, 1982
TCL Archive NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen November 25, 2005
TCL Archive In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society June 27, 1997
